Insight Molecular Diagnostics Inc. (IMDX)
NASDAQ · Healthcare
Insight Molecular Diagnostics Inc. Shareholder Equity 2020–2025
Insight Molecular Diagnostics Inc. annual shareholder equity history from 2020 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Insight Molecular Diagnostics Inc. shareholder equity as of December 31, 2025: -31.5M, a 156.35% increase year-over-year.
- Insight Molecular Diagnostics Inc. shareholder equity for 2025 were -31.5M, a 156.35% increase from 2024.
- Insight Molecular Diagnostics Inc. shareholder equity for 2024 were -12.3M, a 159.97% decrease from 2023.
- Insight Molecular Diagnostics Inc. shareholder equity for 2023 were 20.5M, a 40.31% decrease from 2022.
- Insight Molecular Diagnostics Inc. shareholder equity for 2022 were 34.3M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Insight Molecular Diagnostics Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $-31 |
| 2024 | $-12 |
| 2023 | $20 |
| 2022 | $34 |
| 2021 | $65 |
| 2020 | $33 |
Insight Molecular Diagnostics Inc. Shareholder Equity — FAQ
Insight Molecular Diagnostics Inc. (IMDX) shareholder equity over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see IMDX's shareholder equity history?
The chart and table above show Insight Molecular Diagnostics Inc.'s shareholder equity by year and by quarter, including the growth rate.